Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Cogent Biosciences at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Cogent Biosciences brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 3812. Its program centres on systemic mastocytosis. It hosts a forum on recognizing the disease from patient and clinician views and supports a symposium on care decisions.

OrganizationASH 2026 Attendance
Biotech
Biotech developing precision therapies for genetically defined diseases; lead drug bezuclastinib, a mutant-KIT inhibitor, is in late-stage trials for systemic mastocytosis and GIST.
Booth
Exhibiting at Booth 3812
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
7:00pm–10:00pm
Clinical Turning Points: Decisions That Shape Care Across the Spectrum of Systemic Mastocytosis
Recognizing the full symptom burden of non-advanced systemic mastocytosis, judging disease control, and deciding when to escalate to disease-directed therapy.
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Cogent Biosciences

Tell us what you sell and we’ll find the people at Cogent Biosciences most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction